Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2)

REFERENCES

• Adachi M., Sampath J., Lan L. B., Sun D., Hargrove P., Flatley R., et al. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J. Biol. Chem. 2002; 277: 38998–39004
   PubMed Web of Science ®Google Scholar
• Anderson P. L., Lamba J., Aquilante C. L., Schuetz E., Fletcher C. V. Pharmacogenetic Characteristics of Indinavir, Zidovudine, and Lamivudine Therapy in HIV-Infected Adults: A Pilot Study. J. Acquir. Immune Defic. Syndr. 2006; 42: 441–449
   PubMed Web of Science ®Google Scholar
• Backstrom G., Taipalensuu J., Melhus H., Brandstrom H., Svensson A. C., Artursson P., et al. Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population. Eur J Pharm Sci 2003; 18: 359–364
   PubMed Web of Science ®Google Scholar
• Bakos E., Evers R., Sinko E., Varadi A., Borst P., Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 2000; 57: 760–768
   PubMed Web of Science ®Google Scholar
• Borst P., de Wolf C., van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflügers Arch 2007; 453: 661–673
   PubMed Web of Science ®Google Scholar
• Bosch T. M., Doodeman V. D., Smits P. H., Meijerman I., Schellens J. H., Beijnen J. H. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population. Mol Diagn Ther 2006; 10: 175–185
   PubMed Web of Science ®Google Scholar
• Bosch T. M., Kjellberg L. M., Bouwers A., Koeleman B. P., Schellens J. H., Beijnen J. H., et al. Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population. Am J Pharmacogenomics 2005; 5: 123–131
   PubMedGoogle Scholar
• Chen Z. S., Lee K., Kruh G. D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 2001; 276: 33747–33754
   PubMed Web of Science ®Google Scholar
• Choi J. H., Ahn B. M., Yi J., Lee J. H., Nam S. W., Chon C. Y., et al. MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics 2007; 17: 403–415
   PubMed Web of Science ®Google Scholar
• Choudhuri S., Klaassen C. D. Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters. Int. J. Toxicol. 2006; 25: 231–259
   PubMed Web of Science ®Google Scholar
• Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–1654
   PubMed Web of Science ®Google Scholar
• Colombo S., Soranzo N., Rotger M., Sprenger R., Bleiber G., Furrer H., et al. Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenet. Genomics 2005; 15: 599–608
   PubMed Web of Science ®Google Scholar
• Conrad S., Kauffmann H. M., Ito K., Deeley R. G., Cole S. P., Schrenk D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet. 2001; 46: 656–663
   PubMed Web of Science ®Google Scholar
• Conrad S., Kauffmann H. M., Ito K., Leslie E. M., Deeley R. G., Schrenk D., et al. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 2002; 12: 321–330
   PubMedGoogle Scholar
• Corpechot C., Ping C., Wendum D., Matsuda F., Barbu V., Poupon R. Identification of a novel 974C–>G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol 2006; 101: 2427–2432
   PubMed Web of Science ®Google Scholar
• Cui Y., Konig J., Buchholz J. K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 1999; 55: 929–937
   PubMed Web of Science ®Google Scholar
• Cusatis G., Gregorc V., Li J., Spreafico A., Ingersoll R. G., Verweij J., et al. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J. Natl. Cancer. Inst. 2006; 98: 1739–1742
   PubMed Web of Science ®Google Scholar
• Dazert P., Meissner K., Vogelgesang S., Heydrich B., Eckel L., Bohm M., et al. Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart. Am. J. Pathol. 2003; 163: 1567–1577
   PubMed Web of Science ®Google Scholar
• de Jong F. A., Marsh S., Mathijssen R. H., King C., Verweij J., Sparreboom A., et al. ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin. Cancer Res. 2004; 10: 5889–5894
   PubMed Web of Science ®Google Scholar
• de Jong F. A., Scott-Horton T. J., Kroetz D. L., McLeod H. L., Friberg L. E., Mathijssen R. H., et al. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Clin. Pharmacol. Ther. 2007; 81: 42–49
   PubMed Web of Science ®Google Scholar
• Deeley R. G., Cole S. P. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 2006; 580: 1103–1111
   PubMed Web of Science ®Google Scholar
• Denk G. U., Soroka C. J., Takeyama Y., Chen W. S., Schuetz J. D., Boyer J. L. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 2004; 40: 585–591
   PubMed Web of Science ®Google Scholar
• Dobbs N. A., Twelves C. J., Gillies H., James C. A., Harper P. G., Rubens R. D. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother. Pharmacol. 1995; 36: 473–476
   PubMed Web of Science ®Google Scholar
• Doerfel C., Rump A., Sauerbrey A., Gruhn B., Zintl F., Steinbach D. In acute leukemia, the polymorphism -211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene. Pharmacogenet. Genomics 2006; 16: 149–150
   PubMed Web of Science ®Google Scholar
• Evers R., de Haas M., Sparidans R., Beijnen J., Wielinga P. R., Lankelma J., et al. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br. J. Cancer 2000; 83: 375–383
   PubMed Web of Science ®Google Scholar
• Faneyte I. F., Kristel P. M., van de Vijver M. J. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer. Anticancer Res. 2004; 24: 2931–2939
   PubMed Web of Science ®Google Scholar
• Fetsch P. A., Abati A., Litman T., Morisaki K., Honjo Y., Mittal K., et al. Localization of the ABCG2 mitoxantrone resistance–associated protein in normal tissues. Cancer Lett. 2006; 235: 84–92
   PubMed Web of Science ®Google Scholar
• Flens M. J., Zaman G. J., van der Valk P., Izquierdo M. A., Schroeijers A. B., Scheffer G. L., et al. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 1996; 148: 1237–1247
   PubMed Web of Science ®Google Scholar
• Fromm M. F. Importance of P–glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 2004; 25: 423–429
   PubMed Web of Science ®Google Scholar
• Fukushima-Uesaka H., Saito Y., Maekawa K., Hasegawa R., Suzuki K., Yanagawa T., et al. Genetic variations of the ABC transporter gene ABCC3 in a Japanese population. Drug Metab. Pharmacokinet. 2007a; 22: 129–135
   PubMed Web of Science ®Google Scholar
• Fukushima-Uesaka H., Saito Y., Tohkin M., Maekawa K., Hasegawa R., Kawamoto M., et al. Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a Japanese population. Drug Metab. Pharmacokinet. 2007b; 22: 48–60
   PubMed Web of Science ®Google Scholar
• Giessmann T., Modess C., Hecker U., Zschiesche M., Dazert P., Kunert-Keil C., et al. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin. Pharmacol. Ther. 2004; 75: 213–222
   PubMed Web of Science ®Google Scholar
• Gradhand U., Lang T., Schaeffeler E., Glaeser H., Tegude H., Klein K., et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype. Pharmacogenomics J. 2008; 8: 42–52
   PubMed Web of Science ®Google Scholar
• Gradhand U., Tegude H., Burk O., Eichelbaum M., Fromm M. F., Konig J. Functional analysis of the polymorphism -211C>T in the regulatory region of the human ABCC3 gene. Life Sci. 2007; 80: 1490–1494
   PubMed Web of Science ®Google Scholar
• Haenisch S., Mossiaguine I., Siegmund W., Cascorbi I. Frequency of single nucleotide polymorphisms in the MRP2 gene in healthy German subjects. European Journal of Clinical Pharmacology 2002; 58: S95
   Web of Science ®Google Scholar
• Haenisch S., Zimmermann U., Dazert E., Wruck C. J., Dazert P., Siegmund W., et al. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J. 2007; 7: 56–65
   PubMed Web of Science ®Google Scholar
• Haimeur A., Conseil G., Deeley R. G., Cole S. P. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug. Metab. 2004; 5: 21–53
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Uchiumi T., Konno T., Ebihara T., Nakamura T., Wada M., et al. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome. Hepatology 2002; 36: 1236–1245
   PubMed Web of Science ®Google Scholar
• Henriksen U., Gether U., Litman T. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. J Cell Sci. 2005; 118: 1417–1426
   PubMed Web of Science ®Google Scholar
• Hirano M., Maeda K., Matsushima S., Nozaki Y., Kusuhara H., Sugiyama Y. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol. Pharmacol. 2005; 68: 800–807
   PubMed Web of Science ®Google Scholar
• Hirouchi M., Suzuki H., Itoda M., Ozawa S., Sawada J., Ieiri I., et al. Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2. Pharm. Res. 2004; 21: 742–748
   PubMed Web of Science ®Google Scholar
• Huang L., Wang Y., Grimm S. ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein. Drug. Metab. Dispos. 2006; 34: 738–742
   PubMed Web of Science ®Google Scholar
• Hulot J. S., Villard E., Maguy A., Morel V., Mir L., Tostivint I., et al. A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenet. Genomics 2005; 15: 277–285
   PubMed Web of Science ®Google Scholar
• Ieiri I., Suzuki H., Kimura M., Takane H., Nishizato Y., Irie S., et al. Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol. Res. 2004; 30: 91–95
   PubMed Web of Science ®Google Scholar
• Imai Y., Asada S., Tsukahara S., Ishikawa E., Tsuruo T., Sugimoto Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol. Pharmacol. 2003; 64: 610–618
   PubMed Web of Science ®Google Scholar
• Imai Y., Nakane M., Kage K., Tsukahara S., Ishikawa E., Tsuruo T., et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 2002; 1: 611–616
   PubMed Web of Science ®Google Scholar
• Ito K., Oleschuk C. J., Westlake C., Vasa M. Z., Deeley R. G., Cole S. P. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 2001a; 276: 38108–38114
   PubMed Web of Science ®Google Scholar
• Ito K., Olsen S. L., Qiu W., Deeley R. G., Cole S. P. Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J. Biol. Chem. 2001b; 276: 15616–15624
   PubMed Web of Science ®Google Scholar
• Ito K., Suzuki H., Horie T., Sugiyama Y. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm. Res. 2005; 22: 1559–1577
   PubMed Web of Science ®Google Scholar
• Ito S., Ieiri I., Tanabe M., Suzuki A., Higuchi S., Otsubo K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 2001; 11: 175–184
   PubMedGoogle Scholar
• Itoda M., Saito Y., Shirao K., Minami H., Ohtsu A., Yoshida T., et al. Eight novel single nucleotide polymorphisms in ABCG2/BCRP in Japanese cancer patients administered irinotacan. Drug Metab. Pharmacokinet. 2003; 18: 212–217
   PubMedGoogle Scholar
• Itoda M., Saito Y., Soyama A., Saeki M., Murayama N., Ishida S., et al. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5¢-untranslated region and exon 28. Drug. Metab. Dispos. 2002; 30: 363–364
   PubMed Web of Science ®Google Scholar
• Izzedine H., Hulot J. S., Villard E., Goyenvalle C., Dominguez S., Ghosn J., et al. Association between ABCC2 Gene Haplotypes and Tenofovir-Induced Proximal Tubulopathy. J. Infect. Dis. 2006; 194: 1481–1491
   PubMed Web of Science ®Google Scholar
• Jada S. R., Lim R., Wong C. I., Shu X., Lee S. C., Zhou Q., et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci. 2007; 98: 1461–1467
   PubMed Web of Science ®Google Scholar
• Janneh O., Owen A., Chandler B., Hartkoorn R. C., Hart C. A., Bray P. G., et al. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP. Aids 2005; 19: 2097–2102
   PubMed Web of Science ®Google Scholar
• Janvilisri T., Shahi S., Venter H., Balakrishnan L., van Veen H. W. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). Biochem. J. 2005; 385: 419–426
   PubMed Web of Science ®Google Scholar
• Janvilisri T., Venter H., Shahi S., Reuter G., Balakrishnan L., van Veen H. W. Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J. Biol. Chem. 2003; 278: 20645–20651
   PubMed Web of Science ®Google Scholar
• Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 1997; 327(Pt 1)305–310
   PubMed Web of Science ®Google Scholar
• Jedlitschky G., Tirschmann K., Lubenow L. E., Nieuwenhuis H. K., Akkerman J. W., Greinacher A., et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004; 104: 3603–3610
   PubMed Web of Science ®Google Scholar
• Kage K., Tsukahara S., Sugiyama T., Asada S., Ishikawa E., Tsuruo T., et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int. J. Cancer 2002; 97: 626–630
   PubMed Web of Science ®Google Scholar
• Kartenbeck J., Leuschner U., Mayer R., Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996; 23: 1061–1066
   PubMed Web of Science ®Google Scholar
• Kawabata S., Oka M., Shiozawa K., Tsukamoto K., Nakatomi K., Soda H., et al. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem. Biophys. Res. Commun. 2001; 280: 1216–1223
   PubMed Web of Science ®Google Scholar
• Keitel V., Burdelski M., Warskulat U., Kuhlkamp T., Keppler D., Haussinger D., et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005; 41: 1160–1172
   PubMed Web of Science ®Google Scholar
• Keitel V., Kartenbeck J., Nies A. T., Spring H., Brom M., Keppler D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000; 32: 1317–1328
   PubMed Web of Science ®Google Scholar
• Keitel V., Nies A. T., Brom M., Hummel-Eisenbeiss J., Spring H., Keppler D. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am. J. Physiol. Gastrointest. Liver. Physiol. 2003; 284: G: 165–174
   Web of Science ®Google Scholar
• Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006; 234: 4–33
   PubMed Web of Science ®Google Scholar
• Kobayashi D., Ieiri I., Hirota T., Takane H., Maegawa S., Kigawa J., et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug. Metab. Dispos. 2005; 33: 94–101
   PubMed Web of Science ®Google Scholar
• Koepsell H., Schmitt B. M., Gorboulev V. Organic cation transporters. Rev Physiol Biochem Pharmacol 2003; 150: 36–90
   PubMed Web of Science ®Google Scholar
• Kondo C., Suzuki H., Itoda M., Ozawa S., Sawada J., Kobayashi D., et al. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm. Res. 2004; 21: 1895–1903
   PubMed Web of Science ®Google Scholar
• König J., Hartel M., Nies A. T., Martignoni M. E., Guo J., Buchler M. W., et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int. J. Cancer 2005; 115: 359–367
   PubMed Web of Science ®Google Scholar
• König J., Seithel A., Gradhand U., Fromm M. F. Pharmacogenomics of human OATP transporters. Naunyn Schmiedeberg's Arch. Pharmacol. 2006; 372: 432–443
   Google Scholar
• Kool M., van der Linden M., de Haas M., Scheffer G. L., de Vree J. M., Smith A. J., et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. U S A 1999; 96: 6914–6919
   PubMed Web of Science ®Google Scholar
• Kubota H., Ishihara H., Langmann T., Schmitz G., Stieger B., Wieser H. G., et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res. 2006; 68: 213–228
   PubMed Web of Science ®Google Scholar
• Lamba J. K., Adachi M., Sun D., Tammur J., Schuetz E. G., Allikmets R., et al. Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons. Hum. Mol. Genet. 2003; 12: 99–109
   PubMed Web of Science ®Google Scholar
• Lang T., Hitzl M., Burk O., Mornhinweg E., Keil A., Kerb R., et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 2004; 14: 155–164
   PubMedGoogle Scholar
• Le Saux O., Urban Z., Tschuch C., Csiszar K., Bacchelli B., Quaglino D., et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000; 25: 223–227
   PubMed Web of Science ®Google Scholar
• Lee K., Klein-Szanto A. J., Kruh G. D. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J. Natl. Cancer. Inst. 2000; 92: 1934–1940
   PubMed Web of Science ®Google Scholar
• Lee Y. M., Cui Y., König J., Risch A., Jäger B., Drings P., et al. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 2004; 14: 213–223
   PubMedGoogle Scholar
• Leggas M., Adachi M., Scheffer G. L., Sun D., Wielinga P., Du G., et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell Biol. 2004; 24: 7612–7621
   PubMed Web of Science ®Google Scholar
• Leier I., Jedlitschky G., Buchholz U., Center M., Cole S. P., Deeley R. G., et al. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 1996; 314(Pt 2)433–437
   PubMed Web of Science ®Google Scholar
• Leier I., Jedlitschky G., Buchholz U., Cole S. P., Deeley R. G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 1994; 269: 27807–27810
   PubMed Web of Science ®Google Scholar
• Leschziner G. D., Andrew T., Pirmohamed M., Johnson M. R. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J. 2007; 7: 154–179
   PubMed Web of Science ®Google Scholar
• Leslie E. M., Letourneau I. J., Deeley R. G., Cole S. P. Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochemistry 2003; 42: 5214–5224
   PubMed Web of Science ®Google Scholar
• Leslie E. M., Mao Q., Oleschuk C. J., Deeley R. G., Cole S. P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol. Pharmacol. 2001; 59: 1171–1180
   PubMed Web of Science ®Google Scholar
• Letourneau I. J., Deeley R. G., Cole S. P. Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1). Pharmacogenet. Genomics 2005; 15: 647–657
   PubMed Web of Science ®Google Scholar
• Letourneau I. J., Slot A. J., Deeley R. G., Cole S. P. Mutational Analysis of a Highly Conserved Proline Residue in Mrp1, Mrp2 and Mrp3 Reveals a Partially Conserved Function. Drug. Metab. Dispos. 2007; 35: 1372–1379
   PubMed Web of Science ®Google Scholar
• Li J., Cusatis G., Brahmer J., Sparreboom A., Robey R. W., Bates S. E., et al. Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients. Cancer Biol. Ther. 2007; 6: 432–438
   PubMed Web of Science ®Google Scholar
• Loe D. W., Deeley R. G., Cole S. P. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J. Pharmacol. Exp. Ther. 2000; 293: 530–538
   PubMed Web of Science ®Google Scholar
• Loos W. J., Gelderblom H., Verweij J., van Boven-van Zomeren D. M., Nooter K., Stoter G., et al. Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis. Anticancer Drugs 2003; 14: 227–232
   PubMed Web of Science ®Google Scholar
• Maliepaard M., Scheffer G. L., Faneyte I. F., van Gastelen M. A., Pijnenborg A. C., Schinkel A. H., et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001; 61: 3458–3464
   PubMed Web of Science ®Google Scholar
• Marzolini C., Paus E., Buclin T., Kim R. B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 2004a; 75: 13–33
   PubMed Web of Science ®Google Scholar
• Marzolini C., Tirona R. G., Kim R. B. Pharmacogenomics of the OATP and OAT families. Pharmacogenomics. 2004b; 5: 273–282
   PubMed Web of Science ®Google Scholar
• Meier Y., Pauli-Magnus C., Zanger U. M., Klein K., Schaeffeler E., Nussler A. K., et al. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 2006; 44: 62–74
   PubMed Web of Science ®Google Scholar
• Meissner K., Heydrich B., Jedlitschky G., Meyer Zu Schwabedissen H., Mosyagin I., Dazert P., et al. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. J. Histochem. Cytochem. 2006; 54: 215–221
   PubMed Web of Science ®Google Scholar
• Merino G., Alvarez A. I., Pulido M. M., Molina A. J., Schinkel A. H., Prieto J. G. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug. Metab. Dispos. 2006; 34: 690–695
   PubMed Web of Science ®Google Scholar
• Merino G., van Herwaarden A. E., Wagenaar E., Jonker J. W., Schinkel A. H. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 2005; 67: 1765–1771
   PubMed Web of Science ®Google Scholar
• Meyer zu Schwabedissen H. E., Jedlitschky G., Gratz M., Haenisch S., Linnemann K., Fusch C., et al. Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug. Metab. Dispos. 2005; 33: 896–904
   PubMed Web of Science ®Google Scholar
• Mizuarai S., Aozasa N., Kotani H. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int. J. Cancer 2004; 109: 238–246
   PubMed Web of Science ®Google Scholar
• Mor-Cohen R., Zivelin A., Rosenberg N., Goldberg I., Seligsohn U. A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients. Hepatol. Res. 2005; 31: 104–111
   PubMed Web of Science ®Google Scholar
• Mor-Cohen R., Zivelin A., Rosenberg N., Shani M., Muallem S., Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem. 2001; 276: 36923–36930
   PubMed Web of Science ®Google Scholar
• Morisaki K., Robey R. W., Ozvegy-Laczka C., Honjo Y., Polgar O., Steadman K., et al. Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother. Pharmacol. 2005; 56: 161–172
   PubMed Web of Science ®Google Scholar
• Moriya Y., Nakamura T., Horinouchi M., Sakaeda T., Tamura T., Aoyama N., et al. Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. Biol Pharm Bull 2002; 25: 1356–1359
   PubMed Web of Science ®Google Scholar
• Niemi M., Arnold K. A., Backman J. T., Pasanen M. K., Godtel-Armbrust U., Wojnowski L., et al. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet. Genomics 2006; 16: 801–808
   PubMed Web of Science ®Google Scholar
• Niemi M., Schaeffeler E., Lang T., Fromm M. F., Neuvonen M., Kyrklund C., et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 2004; 14: 429–440
   PubMedGoogle Scholar
• Nies A. T., Jedlitschky G., König J., Herold-Mende C., Steiner H. H., Schmitt H. P., et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004; 129: 349–360
   PubMed Web of Science ®Google Scholar
• Nies A. T., Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflügers Arch. 2006
   PubMed Web of Science ®Google Scholar
• Nies A. T., Spring H., Thon W. F., Keppler D., Jedlitschky G. Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. J. Urol. 2002; 167: 2271–2275
   PubMed Web of Science ®Google Scholar
• Norris M. D., Smith J., Tanabe K., Tobin P., Flemming C., Scheffer G. L., et al. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol. Cancer Ther. 2005; 4: 547–553
   PubMed Web of Science ®Google Scholar
• Oleschuk C. J., Deeley R. G., Cole S. P. Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3. Am. J. Physiol. Gastrointest. Liver. Physiol. 2003; 284(G)280–289
   Web of Science ®Google Scholar
• Paulusma C. C., Kool M., Bosma P. J., Scheffer G. L., ter Borg F., Scheper R. J., et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997; 25: 1539–1542
   PubMed Web of Science ®Google Scholar
• Perdu J., Germain D. P. Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum. Hum Mutat 2001; 17: 74–75
   PubMed Web of Science ®Google Scholar
• Plasschaert S. L., de Bont E. S., Boezen M., vander Kolk D. M., Daenen S. M., Faber K. N., et al. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin. Cancer Res. 2005; 11: 8661–8668
   PubMed Web of Science ®Google Scholar
• Qian Y. M., Song W. C., Cui H., Cole S. P., Deeley R. G. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J. Biol. Chem. 2001; 276: 6404–6411
   PubMed Web of Science ®Google Scholar
• Rao V. V., Dahlheimer J. L., Bardgett M. E., Snyder A. Z., Finch R. A., Sartorelli A. C., et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. U S A 1999; 96: 3900–3905
   PubMed Web of Science ®Google Scholar
• Rau T., Erney B., Gores R., Eschenhagen T., Beck J., Langer T. High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin. Pharmacol. Ther. 2006; 80: 468–476
   PubMed Web of Science ®Google Scholar
• Reid G., Wielinga P., Zelcer N., De Haas M., Van Deemter L., Wijnholds J., et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 2003a; 63: 1094–1103
   PubMed Web of Science ®Google Scholar
• Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. U S A 2003b; 100: 9244–9249
   PubMed Web of Science ®Google Scholar
• Rigato I., Pascolo L., Fernetti C., Ostrow J. D., Tiribelli C. The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem. J. 2004; 383: 335–341
   PubMed Web of Science ®Google Scholar
• Risch A., Müller P., Asher N., Bar-Cohen S., Bartsch H., Rund D. Polymorphisms in transporter genes and chemotherapy response in acute myeloid leukemia (AML) patients from Israel. Naunyn Schmiedeberg's Arch. Pharmacol. 2006; 372(supplement 1), 144 (abstract)
   Google Scholar
• Ritter C. A., Jedlitschky G., Meyer zu Schwabedissen H., Grube M., Kock K., Kroemer H. K. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 2005; 37: 253–278
   PubMed Web of Science ®Google Scholar
• Rius M., Nies A. T., Hummel-Eisenbeiss J., Jedlitschky G., Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003; 38: 374–384
   PubMed Web of Science ®Google Scholar
• Rizwan A. N., Burckhardt G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm. Res. 2007; 24: 450–470
   PubMed Web of Science ®Google Scholar
• Robey R. W., Honjo Y., Morisaki K., Nadjem T. A., Runge S., Risbood M., et al. Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br. J. Cancer 2003; 89: 1971–1978
   PubMed Web of Science ®Google Scholar
• Rothnie A., Callaghan R., Deeley R. G., Cole S. P. Role of GSH in estrone sulfate binding and translocation by the multidrug resistance protein 1 (MRP1/ABCC1). J. Biol. Chem. 2006; 281: 13906–13914
   PubMed Web of Science ®Google Scholar
• Saito S., Iida A., Sekine A., Miura Y., Ogawa C., Kawauchi S., et al. Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR). J.Hum. Genet. 2002; 47: 147–171
   PubMed Web of Science ®Google Scholar
• Sandusky G. E., Mintze K. S., Pratt S. E., Dantzig A. H. Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays. Histopathology 2002; 41: 65–74
   PubMed Web of Science ®Google Scholar
• Schaub T. P., Kartenbeck J., Konig J., Vogel O., Witzgall R., Kriz W., et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J. Am. Soc. Nephrol. 1997; 8: 1213–1221
   PubMed Web of Science ®Google Scholar
• Scheffer G. L., Kool M., de Haas M., de Vree J. M., Pijnenborg A. C., Bosman D. K., et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab. Invest. 2002a; 82: 193–201
   PubMed Web of Science ®Google Scholar
• Scheffer G. L., Pijnenborg A. C., Smit E. F., Muller M., Postma D. S., Timens W., et al. Multidrug resistance related molecules in human and murine lung. J. Clin. Pathol. 2002b; 55: 332–339
   PubMed Web of Science ®Google Scholar
• Schellens J. H., Maliepaard M., Scheper R. J., Scheffer G. L., Jonker J. W., Smit J. W., et al. Transport of topoisomerase I inhibitors by the breast cancer resistance protein. Potential clinical implications. Ann. N Y Acad. Sci. 2000; 922: 188–194
   PubMed Web of Science ®Google Scholar
• Schuetz E. G., Strom S., Yasuda K., Lecureur V., Assem M., Brimer C., et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 2001; 276: 39411–39418
   PubMed Web of Science ®Google Scholar
• Schuetz J. D., Connelly M. C., Sun D., Paibir S. G., Flynn P. M., Srinivas R. V., et al. MRP4: A previously unidentified factor in resistance to nucleoside–based antiviral drugs. Nat. Med. 1999; 5: 1048–1051
   PubMed Web of Science ®Google Scholar
• Schwab M., Eichelbaum M., Fromm M. F. Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev. Pharmacol. Toxicol. 2003; 43: 285–307
   PubMed Web of Science ®Google Scholar
• Shoda J., Suzuki H., Sugiyama Y., Hirouchi M., Utsunomiya H., Oda K., et al. Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol. Res. 2003; 27: 323–326
   PubMed Web of Science ®Google Scholar
• Soranzo N., Cavalleri G. L., Weale M. E., Wood N. W., Depondt C., Marguerie R., et al. Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res 2004; 14: 1333–1344
   PubMed Web of Science ®Google Scholar
• Sparreboom A., Gelderblom H., Marsh S., Ahluwalia R., Obach R., Principe P., et al. Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin. Pharmacol. Ther. 2004; 76: 38–44
   PubMed Web of Science ®Google Scholar
• Sparreboom A., Loos W. J., Burger H., Sissung T. M., Verweij J., Figg W. D., et al. Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol. Ther. 2005; 4: 650–658
   PubMed Web of Science ®Google Scholar
• Steinbach D., Lengemann J., Voigt A., Hermann J., Zintl F., Sauerbrey A. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia. Clin. Cancer Res. 2003a; 9: 1083–1086
   PubMed Web of Science ®Google Scholar
• Steinbach D., Wittig S., Cario G., Viehmann S., Mueller A., Gruhn B., et al. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood 2003b; 102: 4493–4498
   PubMed Web of Science ®Google Scholar
• Stojic J., Stohr H., Weber B. H. Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol. Biol. 2007; 8: 42
   PubMed Web of Science ®Google Scholar
• St-Pierre M. V., Serrano M. A., Macias R. I., Dubs U., Hoechli M., Lauper U., et al. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000; 279: R1495–1503
   PubMed Web of Science ®Google Scholar
• Suzuki H., Sugiyama Y. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition. Adv. Drug. Deliv. Rev. 2002; 54: 1311–1331
   PubMed Web of Science ®Google Scholar
• Tamura A., Wakabayashi K., Onishi Y., Takeda M., Ikegami Y., Sawada S., et al. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci. 2007; 98: 231–239
   PubMed Web of Science ®Google Scholar
• Tamura A., Watanabe M., Saito H., Nakagawa H., Kamachi T., Okura I., et al. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol. Pharmacol. 2006; 70: 287–296
   PubMed Web of Science ®Google Scholar
• Tate G., Li M., Suzuki T., Mitsuya T. A new mutation of the ATP-binding cassette, sub-family C, member 2 (ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Genes Genet Syst 2002; 77: 117–121
   PubMed Web of Science ®Google Scholar
• Toh S., Wada M., Uchiumi T., Inokuchi A., Makino Y., Horie Y., et al. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet 1999; 64: 739–746
   PubMed Web of Science ®Google Scholar
• Torky A. R., Stehfest E., Viehweger K., Taege C., Foth H. Immuno-histochemical detection of MRPs in human lung cells in culture. Toxicology 2005; 207: 437–450
   PubMed Web of Science ®Google Scholar
• van Aubel R. A., Smeets P. H., Peters J. G., Bindels R. J., Russel F. G. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 2002; 13: 595–603
   PubMed Web of Science ®Google Scholar
• van Aubel R. A., Smeets P. H., van den Heuvel J. J., Russel F. G. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am. J. Physiol. Renal Physiol. 2005; 288: F: 327–333
   Web of Science ®Google Scholar
• Vethanayagam R. R., Wang H., Gupta A., Zhang Y., Lewis F., Unadkat J. D., et al. Functional analysis of the human variants of breast cancer resistance protein: I206L, N590Y, and D620N. Drug. Metab. Dispos. 2005; 33: 697–705
   PubMed Web of Science ®Google Scholar
• Vogelgesang S., Kunert-Keil C., Cascorbi I., Mosyagin I., Schroder E., Runge U., et al. Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin. Neuropathol. 2004; 23: 223–231
   PubMed Web of Science ®Google Scholar
• Wall A. M., Gajjar A., Link A., Mahmoud H., Pui C. H., Relling M. V. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia 2000; 14: 221–225
   PubMed Web of Science ®Google Scholar
• Wang H., Hao B., Zhou K., Chen X., Wu S., Zhou G., et al. Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association studies. Ann Hum Genet 2004; 68: 563–573
   PubMed Web of Science ®Google Scholar
• Wang X., Furukawa T., Nitanda T., Okamoto M., Sugimoto Y., Akiyama S., et al. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol. Pharmacol. 2003; 63: 65–72
   PubMed Web of Science ®Google Scholar
• Wang X., Nitanda T., Shi M., Okamoto M., Furukawa T., Sugimoto Y., et al. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem. Pharmacol. 2004; 68: 1363–1370
   PubMed Web of Science ®Google Scholar
• Wang Z., Wang B., Tang K., Lee E. J., Chong S. S., Lee C. G. A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection. Hum. Mol. Genet. 2005; 14: 2075–2087
   PubMed Web of Science ®Google Scholar
• Wielinga P. R., Reid G., Challa E. E., van der Heijden I., van Deemter L., de Haas M., et al. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol. Pharmacol. 2002; 62: 1321–1331
   PubMed Web of Science ®Google Scholar
• Wielinga P. R., van der Heijden I., Reid G., Beijnen J. H., Wijnholds J., Borst P. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J. Biol. Chem. 2003; 278: 17664–17671
   PubMed Web of Science ®Google Scholar
• Wijnholds J., Mol C. A., van Deemter L., de Haas M., Scheffer G. L., Baas F., et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. U S A 2000; 97: 7476–7481
   PubMed Web of Science ®Google Scholar
• Wojnowski L., Kulle B., Schirmer M., Schluter G., Schmidt A., Rosenberger A., et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 2005; 112: 3754–3762
   PubMed Web of Science ®Google Scholar
• Yanase K., Tsukahara S., Mitsuhashi J., Sugimoto Y. Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development. Cancer Lett. 2006; 234: 73–80
   PubMed Web of Science ®Google Scholar
• Zamber C. P., Lamba J. K., Yasuda K., Farnum J., Thummel K., Schuetz J. D., et al. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 2003; 13: 19–28
   PubMedGoogle Scholar
• Zamek-Gliszczynski M. J., Nezasa K. I., Tian X., Bridges A. S., Lee K., Belinsky M. G., et al. Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3-/- and Abcc4-/- Mice. J. Pharmacol. Exp. Ther. 2006; 319: 1485–1491
   PubMed Web of Science ®Google Scholar
• Zelcer N., Reid G., Wielinga P., Kuil A., van der Heijden I., Schuetz J. D., et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem. J. 2003; 371: 361–367
   PubMed Web of Science ®Google Scholar
• Zelcer N., Saeki T., Reid G., Beijnen J. H., Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol.Chem. 2001; 276: 46400–46407
   PubMed Web of Science ®Google Scholar
• Zelcer N., van de Wetering K., de Waart R., Scheffer G. L., Marschall H. U., Wielinga P. R., et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J. Hepatol. 2006; 44: 768–775
   PubMed Web of Science ®Google Scholar
• Zelcer N., van de Wetering K., Hillebrand M., Sarton E., Kuil A., Wielinga P. R., et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc. Natl. Acad. Sci. U S A 2005; 102: 7274–7279
   PubMed Web of Science ®Google Scholar
• Zhang D. W., Cole S. P., Deeley R. G. Determinants of the substrate specificity of multidrug resistance protein 1: role of amino acid residues with hydrogen bonding potential in predicted transmembrane helix 17. J. Biol. Chem. 2002; 277: 20934–20941
   PubMed Web of Science ®Google Scholar
• Zhang D. W., Gu H. M., Vasa M., Muredda M., Cole S. P., Deeley R. G. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry 2003; 42: 9989–10000
   PubMed Web of Science ®Google Scholar
• Zhang W., Yu B. N., He Y. J., Fan L., Li Q., Liu Z. Q., et al. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin. Chim. Acta 2006; 373: 99–103
   PubMed Web of Science ®Google Scholar